Lv1
50 积分 2025-02-21 加入
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity
1个月前
已完结
Decoding cancer across scales with metabolomics
2个月前
已完结
Decoding cancer across scales with metabolomics
2个月前
已完结
Targeting HER2-positive breast cancer: advances and future directions
2个月前
已完结
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis
2个月前
已完结
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: A systematic review and meta-analysis
4个月前
已完结
144P Real-world risk of recurrence (ROR) and health care resource utilization (HCRU) in patients (pts) with HR+/HER2− early breast cancer (EBC) from a UK cancer registry
4个月前
已关闭
Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer
4个月前
已完结
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
4个月前
已完结
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
4个月前
已完结
皖公网安备34019202002308
